Strategic clinical drug development
ljpmedical provides early clinical drug development expertise to biotech start-ups to mid-size pharma companies, predominantly with advanced biologics in oncology, immunology and rare diseases. Established in 2005, we have assisted numerous customers globally with strategic clinical drug development, from the first target product profile, competitor analysis, synopsis, protocols, and clinical development plans. We are your trusted partner for medical input and review of key regulatory documents (e.g. IB, IND, CTA, ODD, PIP, CTD, and BLA).
ljpmedical is an established vendor to KLIFO Drug Development Council and NDA Regulatory Group.
Contact
President, CEO Lars J. Petersen, Professor MD DMSc CBA
Business address: Ryttervænget 5, DK-9000 Aalborg, Denmark
E-mail: ljp@ljpmedical.com
Mobile: +45 6160 5951
SkypeID: larsjpetersen
LinkedIn: https://www.linkedin.com/in/lars-j-petersen-md-dmsc-a014b445/